Skip to main content
logo
BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0030
-0.0015 (-33.33%)
At close: Oct 12, 2026

BioRegenx Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.771.852.343.410.043.99
Revenue Growth
-23.43%-20.75%-31.40%7991.78%-98.94%-48.79%
Gross Profit
1.451.51.662.31-0.012.56
Operating Income
-0.38-0.52-6.55-3.41-0.08-3.25
Net Income
-1.3-1.54-23.05-3.6-0.08-4.72
Earnings Per Share
-0.00-0.00-0.03-0.01-0.00-0.13
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.050.070.060.1300.88
Total Debt
2.172.212.161.490.243.51
Net Cash (Debt)
-2.12-2.15-2.11-1.36-0.24-2.62
Net Cash Growth
------
Net Cash Per Share
-0.00-0.00-0.00-0.00-0.00-0.07

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
0.030.04-0.32-1.52-0.06-3.93
Capital Expenditures
-0.01-0.01-0.19---0.03
Free Cash Flow
0.020.03-0.51-1.52-0.06-3.96
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
81.90%81.08%70.87%67.76%-25.52%64.13%
Operating Margin
-21.30%-27.98%-279.93%-99.92%-185.74%-81.57%
Pretax Margin
-73.81%-83.23%-985.17%-105.53%-185.74%-118.37%
Profit Margin
-73.81%-83.23%-985.17%-105.53%-185.74%-118.37%
FCF Margin
1.07%1.61%-21.95%-44.41%-153.35%-99.39%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
154.64414.83----
PS Ratio
1.656.693.68---